CTLA4

5 registered clinical trials studyying CTLA4 — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Intrathecal Dual Checkpoint Inhibitor (PD-1 and CTLA-4) in Combination With Pemetrexed for Leptomeningeal Meta NCT06809530	Guangzhou Medical University	Phase 1 / Phase 2
Enrolling By Invitation	CNCMT：a Multi-center, Prospective, Single-arm Study NCT06714084	Hubei Cancer Hospital	N/A
Active Not Recruiting	PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Pr NCT04634058	Shanghai Zhongshan Hospital	Phase 2
Recruiting	Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors NCT04842812	Second Affiliated Hospital of Guangzhou Medical University	Phase 1
Recruiting	Novel Genetic Disorders of the Immune System NCT02257892	National Institute of Allergy and Infectious Diseases (NIAID)	—